Prostate specific antigen based biennial screening is sufficient to detect almost all prostate cancers while still curable

J Hugosson, G Aus, H Lilja, P Lodding, CG Pihl… - The Journal of …, 2003 - Elsevier
PURPOSE: We evaluated whether biennial screening with prostate specific antigen (PSA)
only is sufficient to detect prostate cancer while still curable. MATERIALS AND METHODS:
In Göteborg, Sweden 9,972 men 50 to 65 years old were randomized to PSA screening.
During 1995 and 1996 these men were invited for a first PSA screening and invited during
1997 and 1998 for a second screening. The screening procedure included PSA
measurement in all men and in those with a PSA of 3 ng./ml. or greater also it included …